ProShares Ultra Health Care is a ETF series of ProShares Trust (series S000014253). Net assets $72.1M as of 2026-05-31. Index fund.
Showing 15 of 70 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co. | — | $9.1M | 1266.72% |
| ProShares GENIUS Money Market ETF | — | $8.5M | 1180.65% |
| Johnson & Johnson | — | $5.7M | 785.55% |
| AbbVie, Inc. | — | $4.0M | 556.83% |
| UnitedHealth Group, Inc. | — | $3.6M | 498.39% |
| Merck & Co., Inc. | — | $3.1M | 426.27% |
| Repurchase Agreement | — | $2.1M | 290.90% |
| Thermo Fisher Scientific, Inc. | — | $1.9M | 267.71% |
| Amgen, Inc. | — | $1.9M | 262.40% |
| Gilead Sciences, Inc. | — | $1.7M | 241.27% |
| Intuitive Surgical, Inc. | — | $1.6M | 218.21% |
| Pfizer, Inc. | — | $1.6M | 215.34% |
| Abbott Laboratories | — | $1.6M | 215.33% |
| Repurchase Agreement | — | $1.3M | 183.06% |
| Bristol-Myers Squibb Co. | — | $1.2M | 168.40% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $72.1M |
| 2026-02-28 | $93.3M |
| 2025-11-30 | $86.0M |
| 2025-08-31 | $66.5M |
| 2025-05-31 | $64.3M |
| 2025-02-28 | $85.9M |
| 2024-11-30 | $85.4M |
| 2024-08-31 | $100.3M |